PILL Performance — Direxion Daily Pharmaceutical & Medical Bull 3X Shares
Data updated: 2026-09-28
PILL returned +53.41% year to date and +253.88% over one year to Jul 2026. Annualised returns are +25.73% over 3 years and −1.77% over 5 years. The fund beat its Trading - Leveraged category average: $100 invested three years ago grew to $199, against $136 for the category, and to $354 over one year, against $105. Volatility over the past three years was 64.17% a year. In the 12 months to Jul 2026 the fund lost a net $3.9M, and assets reached $20.65M.
PILL Growth of $100
What $100 invested in Direxion Daily Pharmaceutical & Medical Bull 3X Shares grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Trading - Leveraged category average over the same months.
| Period | PILL | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $354 | $105 |
| 3 years (Aug 2023 – Jul 2026) | $199 | $136 |
| 5 years (Aug 2021 – Jul 2026) | $91 | $130 |
| Since data start (Aug 2019 – Jul 2026) | $127 | $147 |
PILL Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +53.41% |
| 1 year | +253.88% |
| 3 years (annualised) | +25.73% |
| 5 years (annualised) | −1.77% |
PILL Annual Returns
Calendar-year total returns of Direxion Daily Pharmaceutical & Medical Bull 3X Shares, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +53.41% |
| 2025 | +74.39% |
| 2024 | −6.92% |
| 2023 | −12.65% |
| 2022 | −43.13% |
| 2021 | −37.17% |
| 2020 | −0.32% |
| 2019 (Aug–Dec) | +63.46% |
PILL Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −5.7% | +9.9% | −19.3% | +19.8% | +1.3% | +44.9% | +4.3% | — | — | — | — | — |
| 2025 | +13.6% | −4.9% | −5.7% | −21.3% | −7.2% | −1.9% | +3.5% | +48.6% | +2.3% | +9.4% | +30.7% | +6.1% |
| 2024 | +1.4% | +16.0% | −9.2% | −22.9% | +3.3% | −4.6% | +26.1% | +7.7% | −2.5% | +9.3% | −1.1% | −19.9% |
| 2023 | +18.4% | −16.6% | −3.4% | +6.0% | −18.7% | +11.6% | +19.2% | −1.4% | −25.3% | −28.4% | +7.4% | +41.0% |
| 2022 | −17.0% | −3.0% | +12.9% | −25.3% | +1.9% | −1.8% | +4.5% | −11.1% | −11.2% | +14.5% | +2.8% | −13.8% |
| 2021 | −1.7% | +7.5% | −17.8% | −6.5% | +7.4% | +7.4% | −9.3% | −11.7% | −7.0% | +2.7% | −14.1% | +2.0% |
| 2020 | −3.6% | −26.8% | −45.2% | +50.7% | +7.3% | −2.7% | −4.0% | +10.9% | −6.8% | +2.9% | +25.4% | +27.8% |
| 2019 | — | — | — | — | — | — | — | −20.4% | +0.8% | +25.9% | +16.8% | +38.5% |
PILL Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 64.17%
- 3-year Sharpe ratio: 0.33 (vs 4.5% risk-free rate)
- Best month: +48.58% (Aug 2025)
- Worst month: −28.43% (Oct 2023)
PILL Fund Flows
Monthly money in and out of Direxion Daily Pharmaceutical & Medical Bull 3X Shares, from SEC Form N-PORT.
- 12-month net flow: −$3.9M
- 12-month gross sales (incl. reinvestments): $10.9M
- Sales ÷ redemptions: 0.74×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $1.9M | $1.9M | $8K |
| Jun 2026 | $824K | $594K | $230K |
| May 2026 | $676K | $0 | $676K |
| Apr 2026 | $0 | $557K | −$557K |
| Mar 2026 | $1.1M | $5.1M | −$4.0M |
| Feb 2026 | $668K | $2.0M | −$1.3M |
| Jan 2026 | $3.1M | $1.8M | $1.2M |
| Dec 2025 | $1.3M | $1.3M | $14K |
| Nov 2025 | $1.0M | $0 | $1.0M |
| Oct 2025 | $0 | $792K | −$792K |
| Sep 2025 | $0 | $796K | −$796K |
| Aug 2025 | $377K | $0 | $377K |
PILL Assets Under Management
Net assets of Direxion Daily Pharmaceutical & Medical Bull 3X Shares by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $20.65M |
| 2026-04-30 | $12.89M |
| 2026-01-31 | $17.93M |
| 2025-10-31 | $11.97M |
| 2025-07-31 | $8.01M |
| 2025-04-30 | $13.58M |
| 2025-01-31 | $15.27M |
| 2024-10-31 | $15.67M |
| 2024-07-31 | $17.23M |
| 2024-04-30 | $12.33M |
| 2024-01-31 | $14.06M |
| 2023-10-31 | $8.18M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.